(Reuters) - U.S. health regulators approved Indian drugmaker Dr Reddy's Laboratories' application to market generic version of AstraZeneca Plc's blood-pressure medicine Toprol-XL. Shares of the company were up 1.51 percent at 1,671 rupees as of 0712 GMT. (Reporting by Kaustubh Kulkarni in Mumbai; Editing by Anand Basu) via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment